The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; none of the 37 sources its claims cite is checked for support yet.
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
Open accessPublished version of a preprint
Abstract
Pericytes put the squeeze on cognition: Like a computer, the brain needs a reliable source of power, which is provided as oxygen and glucose in the blood. However, in many neurological disorders this energy supply is disrupted. Brain blood flow is controlled by adjustment of the diameters of the vessels supplying the blood. Nortley et al. found that, both in humans developing Alzheimer's disease (AD) and in a mouse model of AD, brain capillaries become squeezed by pericytes (see the Perspective by Liesz). By defining the underlying mechanism, they suggest potential targets for therapy in early AD. Science , this issue p. eaav9518 ; see also p. 223
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Amyloid β oligomers constrict human and rodent brain capillaries at pericyte locations via reactive oxygen species, endothelin-1, and pericyte ETA receptors. In human cognitive-decline biopsies and an AD mouse model, this pericyte-mediated capillary constriction is predicted to substantially reduce cerebral blood flow and can be reversed by C-type natriuretic peptide.
Key findings
- Soluble Aβ1–42 constricted all 4 human capillaries tested by ~25% after 40 min (p=0.01); in rat slices, 16/20 capillaries (80%) constricted >5%, reaching ~15% after 1 h (p=0.006), with an apparent EC50 of 4.7 nM.
- The Aβ-evoked constriction was blocked by ETA receptor blocker BQ-123 (p=0.008), SOD1 (p=3.7×10⁻⁶), NADPH oxidase inhibitor DPI (p=0.032), and NOX4 blocker GKT137831 (p=0.0011); NOX2 blocker ebselen reduced it by only 45%. Aβ increased ROS in pericytes 7.28-fold (p=0.001) versus 1.76-fold in Iba1-expressing immune cells (p=0.05), giving 6.4-fold more total ROS generation by pericytes.
- In rapidly fixed biopsies from 13 living patients with cognitive decline, 7 had Aβ deposition and 6 did not. Mean capillary diameter was 8.1% smaller with Aβ deposition (p=0.0007); near pericyte somata, diameter was ~25% larger in no-Aβ patients (p=3.7×10⁻⁷) but ~30% smaller in Aβ-deposition patients (p=1.6×10⁻²⁰), predicted to reduce flow by ~50% (Discussion; Methods calculation gives 58%).
- In APPNL-G-F AD mice in vivo, capillary diameter was smaller (p=1.7×10⁻⁹) and more strongly reduced at pericyte somata (p=1.6×10⁻¹⁷), while arterioles and venules were not constricted; cerebellar capillaries showed no constriction. CNP (100 nM) reversed Aβ-evoked capillary constriction (p=0.029), whereas combined NOX4 + ETA blockade prevented further constriction (p=0.027) but did not reverse diameter to baseline within 1 h.
Methods
- Live human cortical slices from neurosurgical tumour-access tissue, rapidly fixed human cortical biopsies from patients with cognitive decline, rat cortical slices, and APPNL-G-F × NG2-DsRed mice were used; methods included immunohistochemistry, two-photon imaging, pericyte Ca²⁺ imaging, ROS/GSH imaging, propidium iodide death assays, and pimonidazole hypoxia labelling.
- Capillary diameters were measured blinded to Aβ status, often as a function of distance from PDGFRβ-labelled pericyte somata; analyses used t-tests, Mann-Whitney tests, linear regression slopes, and Holm-Bonferroni correction.
- Flow effects were estimated from Poiseuille’s law, assuming pericytes spaced at 2L and capillary constriction near somata.
Limitations
- Stated: limited live human tissue precluded detailed mechanistic analysis; the authors cannot rule out that ETA receptors are on a different cell type; the Aβ deposition measure may largely reflect plaques; GSH changes cannot be converted to ROS synthesis rates; future work is needed on ageing humans who accumulate Aβ without AD and on ET receptor affinity in AD mice.
- Evident from the text: human biopsy data come from a small cohort (13 patients; subgroups of 6 no Aβ, 3 moderate, 4 severe), live human slice data are very limited (94 pericytes from 2 patients; 4 capillaries for Aβ), most mechanistic work is in rat slices, and the in vivo AD mouse data are from ~4-month-old mice.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 37 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the processes of 36% of pericytes labeled for α smooth muscle actin (Fig. 1D)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Applying soluble Aβ1−42 (oligomeric + monomeric, 72 nM calculated from the monomeric MW) to human brain slices evoked a slowly developing constriction of all 4 capillaries tested, which reduced their diameter by ~25% after 40 mins (Fig. 1H, significantly reduced, p=0.01).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ1−42 evoked a constriction of rat capillaries near pericyte locations”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“hypoxic tissue labeling by pimonidazole (hypoxyprobe) was increased significantly in vivo in the AD mice (Fig. S7).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Hypoxia is increased in the AD cortex
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and the diameter at pericyte somata was more strongly reduced (Fig. 5E, p=1.6x10-17).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in vivo in AD mice
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The Aβ1−42-evoked capillary constriction in rat cortical slices was blocked by the endothelin-1 (ET) type A receptor blocker BQ-123 (1 μM, p=0.008, Fig. 2E, G)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“whereas the NOX2 blocker ebselen (2 μM) reduced the constriction by only 45% (n=8, p=0.027”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In patients with no detectable Aβ deposition the capillary diameter increased at locations near pericyte somata compared to at locations far from the somata (~25% larger, slope of line is significantly less than zero, p=3.7x10-7 for 813 data points from 6 such patients, Fig. 4D).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in human cognitive decline patients with Aβ deposition
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we found no significant change in capillary density (12% larger in subjects depositing Aβ, p=0.56, see Materials and Methods).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in human cognitive decline patients with Aβ deposition
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ET still evoked a constriction in the presence of SOD1 (p=1.3x10-8, Fig. 2I)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 24
- Probably not a substantial claim. 32
In the paper
“The mean distance between human pericytes was 65.3±0.4 μm (for 94 pericytes imaged in tissue from 2 patients), 30% larger than in rodents (19).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
What the sources say
- Not checked yetcites [19] Hall CN Reynell C Gesslein B Hamilton NB Mishra A Sutherland BA O’Farrell FM Buchan AM Lauritzen M Attwell D Capillary pericytes regulate cerebral blood flow in health and disease Nature 2014 508 55 60 24670647 PMC3976267 source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“superfused noradrenaline constricted and glutamate dilated the capillaries at pericyte locations (Fig. 1E, F).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Capillaries monitored for an hour without applying Aβ, or those to which a version of Aβ1−42 with a scrambled sequence was applied (prepared as for the Aβ oligomers), showed no significant diameter change (Fig. 2C, G).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Amyloid β constricts human capillaries at pericytes
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ1−42 (72 nM, applied for 40 mins) evoked an increase in ROS level that was suppressed by the presence of SOD1 (Fig. 3A, B).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ increased ROS production in pericytes by a factor of 7.28 (p=0.001) and in immune (Iba1-expressing) cells by a factor of 1.76 (p=0.05).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This prevented further constriction evoked by Aβ(p=0.027), but did not reverse the capillary diameter to its baseline value on a 1 hour time scale (Fig. 6A).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reversal of Aβ-evoked capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which was blocked by the ETA blocker BQ-123 (1 μM, p=2.6x10-11), but not by the ETB blocker BQ-788 (1 μM, p=0.91, Fig. 2H).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ (72 nM for 40 mins) reduced the GSH level in pericytes by 20% and in microglia by 55% (Fig. S4, p=0.014 and p=2x10-29 respectively).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In cerebellum, both WT and AD mice (n=3 each) showed a larger capillary diameter near pericyte somata (Fig. 5G, p=0.002), with no evidence for a constriction in the AD mice.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in vivo in AD mice
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“applying ET (10 nM) evoked a rise in [Ca2+]i while aCSF had no effect (Fig. 2K-L).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, applying these agents alone did not affect capillary diameter (changes after 1 hour were: BQ-123, -0.7±5.2%, n=13, p=0.9; SOD1, 3.4±5.8%, n=9, p=0.57; DPI, -7.4±3.2%, n=5, p=0.082).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It was not possible to make pure monomeric preparations of Aβ1-42 or Aβ1-40.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Oligomerising Aβ and assessing the form and concentration of Aβ applied
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Healthy capillaries (<10 μm in diameter, mean diameter 5.61±0.03 μm (n=299) in rat, and 5.08±0.33 μm (n=12) in human, with no rings of arteriolar smooth muscle around them) were selected as previously described (41)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging capillaries in brain slices
Strength:plain· not yet calibratedn = 12Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ1-42 and Aβ1-40 formed monomers and oligomers, while scrambled Aβ1-42 formed mainly monomers (Fig. 1G).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Oligomerising Aβ and assessing the form and concentration of Aβ applied
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Healthy capillaries (<10 μm in diameter, mean diameter 5.61±0.03 μm (n=299) in rat, and 5.08±0.33 μm (n=12) in human, with no rings of arteriolar smooth muscle around them) were selected as previously described (41)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging capillaries in brain slices
Strength:plain· not yet calibratedn = 299Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean age of patients without Aβ deposition was 50.5±5.5 (n=6, 4 women and 2 men), and of those with Aβ deposition was 62.1±4.2 (n=7, 4 women and 3 men, not significantly different, p=0.11).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human biopsy data
Strength:plain· not yet calibratedn = 7Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mice aged ~4 months (P119-P143, not significantly different for WT and AD, p=0.13) were anesthetised using urethane (1.55 g/kg given in two doses 15 minutes apart).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Experiments in vivo on AD mice
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Regressing mean capillary diameter against age from all patients, or from the patients lacking Aβ deposition, showed that there was no significant dependence on age (p=0.5 and p=0.82 respectively).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human biopsy data
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Cerebral blood flow in the grey matter can be reduced by over 40% (3)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [3] Asllani I Habeck C Scarmeas N Borogovac A Brown TR Stern Y Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease J Cereb Blood Flow Metab 2008 28 725 736 17960142 PMC2711077 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“reduced blood flow increases Aβ production (13, 14).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [13] Sun X He G Qing H Zhou W Dobie F Cai F Staufenbiel M Huang LE Song W Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression Proc Natl Acad Sci USA 2006 103 18727 18732 17121991 PMC1693730 source
- Not checked yetcites [14] Zhang X Zhou K Wang R Cui J Lipton SA Liao FF Xu H Zhang YW Hypoxia-inducible factor 1α(HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation J Biol Chem 2007 282 10873 10880 17303576 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A subset of pericytes on capillary walls is contractile (these are the only contractile cells on capillaries (18))”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [18] Peppiatt CM Howarth C Mobbs PG Attwell D Bidirectional control of CNS capillary diameter by pericytes Nature 2006 443 700 704 17036005 PMC1761848 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Aβ1−42 oligomers, the molecular species believed to be responsible for Aβ’s toxic effects in AD (22, 23).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [22] Klein WL Krafft GA Finch CE Targeting small Aβ oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci 2001 24 219 224 11250006
- Not checked yetcites [23] Attems J Lintner F Jellinger KA Amyloid β peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology Acta Neuropathol 2004 107 283 291 14986026
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Exogenous amyloid β can reduce cerebral blood flow (10–12)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Abstract
What the sources say
- Not checked yetcites [10] Suo Z Humphrey J Kundtz A Sethi F Placzek A Crawford F Mullan M Soluble Alzheimer’s β-amyloid constricts the cerebral vasculature in vivo Neurosci Lett 1998 257 77 80 9865931
- Not checked yetcites [11] Deane R Du Yan S Submamaryan RK LaRue B Jovanovic S Hogg E Welch D Manness L Lin C Yu J Zhu H RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nat Med 2003 9 907 913 12808450 source
- Not checked yetcites [12] Dietrich HH Xiang C Han BH Zipfel GJ Holtzman DM Soluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cells Molec Neurodegen 2010 5 15 PMC2873254 20388225
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the cells showing the brightest oxidised dihydroethidium fluorescence were located on capillaries, had the morphology of pericytes, and labeled for NG2 but not Iba1 (Fig. 3C), implying that they are pericytes.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reactive oxygen species and endothelin-1 generate the capillary constriction
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For each z-stack, a mean intensity per pericyte or Iba-1-labeled cell, and the total intensity per population of pericytes or Iba1-labeled cells, were calculated, and analysis was performed using the z-stack as the statistical unit.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging ROS production
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The work on fresh living human brain tissue received ethical approval from the National Health Service (REC number 15/NW/0568) and all patients gave informed consent.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human brain slices
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“Cellular production of reactive oxygen species (ROS) in brain slices was visualised through the O2.-specific oxidation of dihydroethidium to ethidium, which binds to the DNA and RNA of O2.-producing cells (46).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging ROS production
What the sources say
- Not checked yetcites [46] Wu L-J Wu G Akhavan Sharif MR Baker A Jia Y Fahey FH Luo HR Feener EP Clapham DE The voltage-gated proton channel, Hv1, enhances brain damage from ischemic stroke Nat Neurosci 2012 15 565 573 22388960 PMC3314139 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“C-type natriuretic peptide (CNP), which can reverse ET-mediated effects (36) by blocking Ca2+ release from internal stores and activating myosin light chain phosphatase (Fig. S8).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Reversal of Aβ-evoked capillary constriction
What the sources say
- Not checked yetcites [36] Špiranec K Chen W Werner F Nikolaev VO Naruke T Koch F Werner A Eder-Negrin P Diéguez-Hurtado R Adams RH Baba HA Endothelial C-type natriuretic peptide acts on pericytes to regulate microcirculatory flow and blood pressure Circulation 2018 138 494 508 29626067 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“In some experiments pericytes were identified prior to imaging by incubating slices for 30 min in 10 μg/ml isolectin B4 conjugated to Alexa 488 or 568 (ThermoFisher I21411 or 121412), which binds to α-D-galactose residues in the basement membrane generated by pericytes and endothelial cells, and outlines pericytes (41).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging capillaries in brain slices
What the sources say
- Not checked yetcites [41] Mishra A O’Farrell FM Reynall C Hamilton NB Hall CN Attwell D Imaging pericytes and capillary diameter in brain slices and isolated retinae Nat Protoc 2014 9 323 336 24434801
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Throughout this work pericytes were identified by their morphology (spatially isolated cells located outside capillaries) as confirmed by isolectin B4 labelling, or by antibody labelling for their characteristic marker PDGFRβ, or by expression of dsRed under the NG2 promoter.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“with the experimenter blinded to the occurrence of Aβ deposition (viewing only the PDGFRβ image channel)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Pericytes constrict capillaries in human cognitive decline patients with Aβ deposition
Strength:plain· not yet calibratedn = 13Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Oligodendrocyte precursor cells (OPCs), identified based on a star-like morphology and weaker baseline fluorescence, and arteriolar smooth muscle cells, were excluded from the analysis.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging pericyte [Ca2+]i
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“No preincubation with DHE was used, to limit the intracellular accumulation of oxidised product.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging ROS production
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Capillary diameter was measured from the resulting movies, by an analyst blinded to the time and identity of drug application, by placing a line across the lumen on magnified images using Metamorph software.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging capillaries in brain slices
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Pericyte responses to noradrenaline and glutamate as documented in Fig. 1 were observed whether or not there was tumour infiltration.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human brain slices
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“To avoid counting cells killed by the slicing procedure, quantification of the percentage of pericytes that were dead excluded cells within 20 μm of the slice surface.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Assessing pericyte death
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Aβ was only applied to slices that showed no tumour infiltration.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human brain slices
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“Capillary constriction by pericytes may explain why some capillaries become occluded by neutrophils in AD (37)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Discussion
What the sources say
- Not checked yetcites [37] Roberts BR Lind M Wagen AZ Rembach A Frugier T Li QX Ryan TM McLean CA Doecke JD Rowe CC Villemagne VL Biochemically-defined pools of amyloid-β in sporadic Alzheimer’s disease: correlation with amyloid PET Brain 2017 140 1486 1498 28383676
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Adequate anesthesia was ensured by confirming the absence of a withdrawal response to a paw pinch.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Experiments in vivo on AD mice
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Data normality was assessed with Shapiro-Wilk or D'Agostino-Pearson omnibus tests.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Statistics
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“P values were corrected for multiple comparisons using a procedure equivalent to the Holm-Bonferroni method (for N comparisons, the most significant p value is multiplied by N, the 2nd most significant by N-1, the 3rd most significant by N-2, etc.; corrected p values are significant if they are less than 0.05).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Statistics
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The dura was left intact, to reduce perturbation of the brain.”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Experiments in vivo on AD mice
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“AD mice, in which APP with a humanised Aβ region containing 3 AD-related mutations (APPNL-G-F) is knocked in (49), to avoid artefacts associated with over-expressing APP, were crossed with NG2-DsRed mice in which pericytes express DsRed (19).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Experiments in vivo on AD mice
What the sources say
- Not checked yetcites [49] Saito T Matsuba Y Mihira N Takano J Nilsson P Itohara S Iwata N Saido TC Single App knock-in mouse models of Alzheimer's disease Nat Neurosci 2014 1 661 663 24728269 source
- Not checked yetcites [19] Hall CN Reynell C Gesslein B Hamilton NB Mishra A Sutherland BA O’Farrell FM Buchan AM Lauritzen M Attwell D Capillary pericytes regulate cerebral blood flow in health and disease Nature 2014 508 55 60 24670647 PMC3976267 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“The sections were additionally immunolabeled with a GSH-NEM antibody (Millipore MAB3194, 1:500) which is specific to this adduct, allowing quantification of reduced glutathione after reaction with NEM (47).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Imaging ROS production
What the sources say
- Not checked yetcites [47] Won SJ Kim JE Cittolin-Santos GF Swanson RA Assessment at the single-cell level identifies neuronal glutathione depletion as both a cause and effect of ischemia-reperfusion oxidative stress J Neurosci 2015 35 7143 7152 25948264 PMC4420782
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Although this measure of Aβ may largely reflect the presence of plaques, it is likely that the soluble Aβ concentration correlates with plaque load (48).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human biopsy data
What the sources say
- Not checked yetcites [48] Murphy MP Levine H III Alzheimer’s disease and the β-amyloid peptide J Alzheimer’s Dis 2010 19 311 323 20061647 PMC2813509
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Images were analysed to assess capillary diameter with the experimenter blinded to the level of Aβ deposits (i.e. viewing only the PDGFRβ channel: the condition of the tissue was sometimes worse for patients with Aβ deposition, but it was not possible to unambiguously decide whether the patient had Aβ deposition without viewing the Aβ channel).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Human biopsy data
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“An estimate of the sample size needed for a typical experiment is as follows: For a control response of 100%, a response standard deviation of 10%, a response in a drug of 70% (30% inhibition), a power of 80% and p<0.05, less than 6 vessels are needed in each of the control and drug groups (www.biomath.info/power/ttest.htm).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Statistics
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“the contractility of capillary pericytes decreases for higher branching orders of capillary (19)”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Calculation of effect of vessel constriction on flow
What the sources say
- Not checked yetcites [19] Hall CN Reynell C Gesslein B Hamilton NB Mishra A Sutherland BA O’Farrell FM Buchan AM Lauritzen M Attwell D Capillary pericytes regulate cerebral blood flow in health and disease Nature 2014 508 55 60 24670647 PMC3976267 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In reality the flow reduction could be greater than this because Poiseuille’s law does not apply for small capillary diameters for which the effective blood viscosity increases as the diameter decreases below 10 μm (50).”
§ Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes > Materials and Methods > Calculation of effect of vessel constriction on flow
What the sources say
- Not checked yetcites [50] Pries AR Secomb TW Gaehtgens P Gross JF Blood flow in microvascular networks. Experiments and simulation Circ Res 1990 67 826 834 2208609
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The authors state this as an assumption.
The ETA receptors involved in ET-evoked pericyte constriction are located on the pericytes themselves.
“We assume that the ETA receptors involved are located on the pericytes themselves, since ET raised the [Ca2+]i in pericytes, but we cannot rule out the possibility that they are on a different cell type.”
The paper relies on this without support.
The soluble Aβ concentration correlates with plaque load.
“although this measure of Aβ may largely reflect the presence of plaques, it is likely that the soluble Aβ concentration correlates with plaque load”
The paper relies on this without support.
In humans, the cerebellum is relatively spared of amyloid plaque pathology.
“an area that is relatively spared of amyloid plaque pathology in humans”
The authors state this as an assumption.
Pericytes are regularly spaced on capillaries at an interval of 2L.
“We assume that pericytes are regularly spaced on capillaries at an interval of 2L.”
The authors state this as an assumption.
Flow in capillaries is governed by Poiseuille's law.
“For flow governed by Poiseuille’s law, the resistance of a segment of capillary of length L (from a pericyte soma to midway between two pericytes) and radius r1 is given by k.L/r14 where k is a constant.”
The authors state this as an assumption.
The reduction in capillary diameter from the midpoint between pericytes to the pericyte soma is linear with distance.
“then if this reduction is linear with distance the resistance of the capillary segment from the soma to the midpoint is given by k.L.(r12+r1.r2+r22)/(3.r13r23)”
The authors state this as an assumption.
The pressure is fixed at the pial end of penetrating arterioles and venules.
“if the pressure is fixed at the pial end of penetrating arterioles and venules”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Such recovery of neuron and NVU morphology is associated with the improvement of neurovascular coupling as indicated by a whisker pad electrical stimulation and laser speckle contrast imaging (LSCI) experiment (Figure 6f).[ 37 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [37]
Experimental — accuracy not yet measuredIn the citing paper
“A recent study shows that the presence of Aβ also causes capillary constriction in human cortical slices by acting on pericytes to generate reactive oxygen species (ROS) leading to endothelin-1 release”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Nortley et al., 2019
In the citing paper
“Similarly, a recent study has suggested that NOX4 in pericytes is the major source of ROS which is involved in the constriction of capillaries early in the response to Aβ [48].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
EC50 result is assigned to two different figures
MinorThe results section places the 4.7 nM EC50 in Fig. 2D, but the methods section says the same measurement is in Fig. 1D. Elsewhere, Fig. 1D is identified as showing α-smooth-muscle-actin labeling of pericytes.
“Thus, the measured EC50 of 4.7 nM for the effect of Aβ1-42 on constriction in Fig. 1D”
“The pericyte-mediated constriction evoked by Aβ1−42 showed a Michaelis-Menten dependence on Aβ concentration, with an apparent EC50 (Km) of 4.7 nM (Fig. 2D).”
Citations
Cites
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · cited 2×
“These data suggest that NOX4 in pericytes or endothelial cells (27–29), rather thanNOX2 in immune cells (28, 29), is the NADPH oxidase mainly responsible for generating the ROS that evoke capillary constriction.”
BackgroundThe precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Molecular Architecture of the Mouse Nervous System
Zeisel, A., Hochgerner, H., Lönnerberg, P., Johnsson, A., Memic, F., van der Zwan, J., Häring, M., Braun, E., Borm, L. E., La Manno, G., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.021 · Cited by 2,552
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Capillary pericytes regulate cerebral blood flow in health and disease
Hall, C. N., Reynell, C., Gesslein, B., Hamilton, N. B., Mishra, A., Sutherland, B. A., O’Farrell, F. M., Buchan, A. M., Lauritzen, M., & Attwell, D. (2014) · Nature · doi:10.1038/nature13165 · Cited by 1,870
Self-citationThe Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Single App knock-in mouse models of Alzheimer’s disease
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N., & Saido, T. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3697 · Cited by 1,366 · cited 1×
“AD mice, in which APP with a humanized Ab region containing three AD-related mutations (App) is knocked in (49) to avoid artifacts associated with overexpressing APP, were crossed with NG2-DsRed mice in which pericytes express DsRed (19).”
BackgroundSelf-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 675
Ferris, H. R., Jeffrey, D. A., Guerrero, M. B., Birnbaumer, L., Zheng, F., & Dabertrand, F. (2025) · Science Signaling · doi:10.1126/scisignal.ads1903 · Cited by 21
Metabolic‐vascular coupling in skeletal muscle: A potential role for capillary pericytes?
Attrill, E., RAMSAY, C. D., Ross, R. M., Richards, S. M., Sutherland, B. A., Keske, M. A., Eringa, E. C., & Premilovac, D. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13208 · Cited by 19
Zhang, Z., Wu, H., Qi, S., Tang, Y., Qin, C., Liu, R., Zhang, J., Cao, Y., & Gao, X. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416426 · Cited by 19
“Raised NO may result from elevated NOS activity, and ET-1 may be released in response to increased ROS levels [35].”
BackgroundMehla, J., Deibel, S. H., Karem, H., Hong, N. S., Hossain, S. R., Lacoursiere, S. G., Sutherland, R. J., Mohajerani, M. H., & McDonald, R. J. (2023) · Communications Biology · doi:10.1038/s42003-023-05506-6 · Cited by 18
“…model is being used more commonly than other APP-KI lines as it develops A β pathology faster 21 and can be used to study various downstream mechanisms such as neuroin fl ammation 27,28 , pericyte signaling 29 , oxidative stress 30 , tau propagation 31 , and spatial memory impairment 25,26,32 .”
The Impact of Aging on the Function of Retinal Ganglion Cells
Prinz, J., Walter, P., Liu, H., & Prokosch, V. (2024) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-2239-0290 · Cited by 19
“However, aging is an important risk factor for endothelial and pericyte dysfunction and loss [67,68].”
BackgroundChaudhuri, S., Cho, M., Stumpff, J., Bice, P. J., İş, Ö., Ertekin‐Taner, N., Saykin, A. J., & Nho, K. T. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00798-0 · Cited by 20
Premont, R. T., Reynolds, J. D. H., Zhang, R., & Stamler, J. S. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8153 · Cited by 19
Dysregulation of Endothelin-1: Implications for Health Disparities in Alzheimer’s Disease
Alcendor, D. J. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040199 · Cited by 18
“suggests that ET-1, which interacts with ETA receptors, may cause pericyte contractions, subsequent capillary constriction, and chronic hypoperfusion of the brain microvasculature in AD patients [57].”
BackgroundInfluentialDiverse mechanisms regulating brain energy supply at the capillary level
Pfeiffer, T., Li, Y., & Attwell, D. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.12.010 · Cited by 21
Self-citationDifferentiation of Brain Pericyte‐Like Cells from Human Pluripotent Stem Cell−Derived Neural Crest
Gastfriend, B. D., Stebbins, M. J., Du, F., Shusta, E. V., & Palecek, S. P. (2021) · Current Protocols · doi:10.1002/cpz1.21 · Cited by 19
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
Merighi, S., Poloni, T. E., Pelloni, L., Pasquini, S., Varani, K., Vincenzi, F., Borea, P. A., & Gessi, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652455 · Cited by 18
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Ibáñez, L., Cruchaga, C., & Fernández, M. V. (2021) · Genes · doi:10.3390/genes12081247 · Cited by 20
“However, it is not clear what damage to synapses and neurons is due to the decrease in energy supply caused by Aβ-induced capillary constriction [19].”
BackgroundFrustrated peptide chains at the fibril tip control the kinetics of growth of amyloid-β fibrils
Xu, Y., Knapp, K., Le, K. N., Schafer, N. P., Safari, M. S., Davtyan, A., Wolynes, P. G., & Vekilov, P. G. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110995118 · Cited by 19
“and dynamics study of amyloid beta peptide (1-42): An in-silico-based analysis to”
BackgroundClark, A. T., Abrahamson, E. E., Harper, M. M., & Ikonomović, M. D. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00301-z · Cited by 18
“This imbalance could be exacerbated by injury- or disease-induced elevations in reactive oxygen species, which cause pericyte contraction [45], or by exposure to high levels of human Aβ forms [45] which has been associated with pericyte contraction in AD and mouse models of the disease [8, 70, 95].”
BackgroundVestergaard, M. B., Lindberg, U., Knudsen, M. H., Urdanibia-Centelles, O., Bakhtiari, A., Mortensen, E. L., Osler, M., Fagerlund, B., Benedek, K., Lauritzen, M., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00596-2 · Cited by 17
“Recent studies in mouse models have also demonstrated that abnormal tau tangles and aβ protein accumulation disrupt the neurovascular coupling, suggesting a mechanistic correlation [50, 51] between reduced cerebrovascular response to activation and development of age-related cognitive decline.”
BackgroundMolecular mechanisms of Alzheimer’s disease: From therapeutic targets to promising drugs
Alan, E., Kerry, Z., & Sevin, G. (2023) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.12861 · Cited by 17
Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases
Nie, T., Li, Y., Tang, F., Duan, Y., Nepovimová, E., Kuča, K., Wu, Q., & Wei, W. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241101093436 · Cited by 20
Tension at the gate: sensing mechanical forces at the blood–brain barrier in health and disease
Hansen, C. E., Hollaus, D., Kamermans, A., & de Vries, H. E. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03321-2 · Cited by 21
Cerasuolo, M., Papa, M., Colangelo, A. M., & Rizzo, M. R. (2023) · Biomedicines · doi:10.3390/biomedicines11030861 · Cited by 18
“Aβ activates ROS formation, which prompts the release of endothelin‐1 (ET‐1) and mediates capillary constriction [24].”
BackgroundInfluentialProbing differences among Aβ oligomers with two triangular trimers derived from Aβ
Kreutzer, A. G., Guaglianone, G., Yoo, S., Parrocha, C. M. T., Ruttenberg, S. M., Malonis, R. J., Tong, K., Lin, Y.-F., Nguyen, J. T., Howitz, W. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219216120 · Cited by 18
“Esbjörner, Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1-42) compared to Aβ(1-40).”
Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer’s Disease
Su, M., Nizamutdinov, D., Liu, H., & Huang, J. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119272 · Cited by 26
“While some studies have pointed to perivascular macrophages as the sources of ROS [168], other studies have found that ROS are produced by microglia and pericytes [166].”
BackgroundSasahara, T., Satomura, K., Tada, M., Kakita, A., & Hoshi, M. M. (2021) · iScience · doi:10.1016/j.isci.2021.102936 · Cited by 17
“…Ab at cerebrovascular vessels (called cerebral amyloid angiopathy (CAA)), leading to a reduction of cerebral blood flow (Binnewijzend et al., 2016, O’brien et al., 1992), dysfunction of the blood-brain barrier (Yamazaki and Kanekiyo, 2017), induction of vascular inflammation (Suo et al., 1998),…”
BackgroundWang, Y., Yan, C., Qi, Y., Zhao, R., Wan, Y., Lyu, Z., Li, Y., Wang, Z., Li, C., Lin, Y., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161138 · Cited by 16
Phase retrieval‐based phase‐contrast CT for vascular imaging with microbubble contrast agent
Tang, R., Li, Y., Qin, L., et al. (2021) · Medical Physics · doi:10.1002/mp.14819 · Cited by 16
Skaaraas, G. H. E. S., Melbye, C., Puchades, M. A., Leung, D. S. Y., Jacobsen, Ø., Rao, S. B., Ottersen, O. P., Leergaard, T. B., & Torp, R. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210571 · Cited by 16
Colca, J. R., & Finck, B. N. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.929328 · Cited by 16
Crouzet, C., Phan, T. P., Wilson, R. H., Shin, T. J., & Choi, B. (2023) · Neurophotonics · doi:10.1117/1.nph.10.2.020601 · Cited by 18
“Furthermore, Aβ oligomers have been shown to produce capillary vasoconstriction via pericyte signaling.(179) This is expected to cause a global reduction in CBF since capillaries are the most common blood vessel in the brain.”
BackgroundNeurovascular glial unit: A target of phytotherapy for cognitive impairments
Chen, L., Zhen, Y., Wang, X., Wang, J., & Zhu, G. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155009 · Cited by 19
Xue, H., Zeng, L., & Liu, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1233601 · Cited by 16
Ultrastructure of precapillary sphincters and the neurovascular unit
Grubb, S. (2023) · Vascular Biology · doi:10.1530/vb-23-0011 · Cited by 15
“While contractility has been proposed for pericytes beyond the fourth-order capillary (27, 28) (thin strand pericytes), this is a very slow process thought to involve cytoskeletal elements like g-or f-actin.”
Kreutzer, A. G., Parrocha, C. M. T., Haerianardakani, S., Guaglianone, G., Nguyen, J. T., Diab, M. N., Yong, W. H., Perez-Rosendahl, M. A., Head, E., & Nowick, J. S. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00592 · Cited by 20
Yan, C., Wang, Y., Ma, Y., Liu, H., Tang, S., Li, Y., Shi, J., Ding, S., & Lyu, Z. (2024) · Materials Today Chemistry · doi:10.1016/j.mtchem.2024.102222 · Cited by 17
A unified model of dementias and age‐related neurodegeneration
Fossel, M. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12012 · Cited by 16
Syndapin-2 mediated transcytosis of amyloid-β across the blood–brain barrier
Leite, D. M., Seifi, M., Ruiz‐Pérez, L., Nguemo, F., Plomann, M., Swinny, J. D., & Battaglia, G. (2022) · Brain Communications · doi:10.1093/braincomms/fcac039 · Cited by 16
“Aβ assemblies were prepared according to previously described protocols.(48,49) Briefly, Aβ (1–40) peptide was dissolved in hexafluoro-2-propanol at 1 mM, vortexed and bath sonicated to obtain a homogenous solution, and aliquoted to microcentrifuge tubes.”
MethodZhou, Q., Zhao, H., Ma, C., Huang, L., Liu, J., Guo, L., Peng, C. Y., & Xiong, L. (2022) · Organic Letters · doi:10.1021/acs.orglett.2c01587 · Cited by 16
Altered hemodynamics and vascular reactivity in a mouse model with severe pericyte deficiency
Stobart, J. L., Erlebach, E., Glück, C., Huang, S., Barrett, M. J. P., Li, M., Vinogradov, S. A., Klohs, J., Zarb, Y., Keller, A., et al. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221147366 · Cited by 14
Martins, A., Zayas‐Santiago, A., Ferrer‐Acosta, Y., Martinez-Jimenez, S. M., Zueva, L. V., Díaz-García, A., & Inyushin, M. Y. (2019) · Biomolecules · doi:10.3390/biom9080350 · Cited by 17
“(2) Aβ oligomers can produce vascular dysregulation by acting on pericytes [46].”
BackgroundLiu, D., Ahmet, I., Griess, B., Tweedie, D., Greig, N. H., & Mattson, M. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20964233 · Cited by 18
“Ab oligomers can also induce constriction of cerebral capillaries that can further reduce CBF and decrease Ab peptide clearance; thus exacerbating Ab oligomer formation and plaque accumulation in AD bains.(41) In 3xTgAD mice, mutant tau pathology is evident early (Figure 3(a)), and its potential role in the early dimi…”
BackgroundResultZhuang, L., Ni, H., Wang, J., Liu, X., Lin, Y., Su, Y., Zhang, K., Li, Y., Peng, G., & Luo, B. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.604246 · Cited by 15
“It is identified recently that Aβ generating reactive oxygen species causes pericyte constriction of brain capillaries can lead to chronic hypoperfusion, exacerbating neurodegeneration and cognitive dysfunction in AD (Nortley et al., 2019).”
BackgroundHirunpattarasilp, C., James, G., de Freitas, F. S. S., Sethi, H., Kittler, J. T., Huo, J., Owens, R. J., & Attwell, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.01.438122 · Cited by 15
Self-citationBernocchi, F., Bonomi, C. G., Assogna, M., Moreschini, A., Mercuri, N. B., Koch, G., Martorana, A., & Motta, C. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.05.002 · Cited by 15
“In the last few years, ET-1 and VEGF emerged as important contributors to CBF regulation and BBB permeability in physiological and pathological conditions including AD (William G. Mayhan, 1999; Ali et al., 2022; Nortley et al., 2019).”
Vascular cognitive impairment: Advances in clinical research and management
You, T., Wang, Y., Chen, S., Dong, Q., Yu, J., & Cui, M. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003220 · Cited by 18
Kozberg, M. G., Munting, L. P., Hanlin, L. H., Auger, C. A., van den Berg, M. L., Denis de Senneville, B., Hirschler, L., Warnking, J. M., Barbier, E. L., Farrar, C. T., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf186 · Cited by 23
“36 However, some studies have shown that amyloid-β causes vasoconstriction, 37,38 including a recent study of dissected and pressurized pial arteries from 18-month-old APP23 mice.”
A nuclear fluorescent dye identifies pericytes at the neurovascular unit
Mai-Morente, S., Marset, V. M., Blanco, F., Isasi, E., & Abudara, V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15193 · Cited by 15
Rahman, S. O., Khan, T. M., Iqubal, A., Agarwal, S., Akhtar, M., Parvez, S., Shah, Z. A., & Najmi, A. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121899 · Cited by 15
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 19
Microvascular and cellular dysfunctions in Alzheimer’s disease: an integrative analysis perspective
Li, M., Hao, X., Hu, Z., Tian, J., Shi, J., Ma, D., Guo, M., Li, S., Zuo, C., Liang, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71888-0 · Cited by 14
“The dysfunction and decrease of pericytes reduce the regulating effect of pericytes on cerebral blood flow, offering a possible explanation for the decreased cerebral blood flow in AD patients 72 .”
BackgroundGradual Not Sudden Change: Multiple Sites of Functional Transition Across the Microvascular Bed
Shaw, K., Boyd, K., Anderle, S., Hammond‐Haley, M., Amin, D., Bonnar, O., & Hall, C. N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.779823 · Cited by 14
“In Alzheimer’s disease, capillaries may mediate functionally significant decreases in cerebral blood flow, as capillaries but not arterioles were found to be constricted due to endogenous Aβ-mediated endothelin signaling to pericytes (Nortley et al., 2019), and to be plugged by neutrophils (Cruz Hernández et al.”
BackgroundThe consequence of endothelial remodelling on the blood spinal cord barrier and nociception
Younis, A. Z., Hardowar, L. D., Barker, S., & Hulse, R. P. (2022) · Current Research in Physiology · doi:10.1016/j.crphys.2022.03.005 · Cited by 14
Zhang, Y.-B., Liu, M., Wang, Y., Hu, D., Wu, S., Zhao, B., Zhou, B., & Yang, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177958 · Cited by 14
Overexpression of fibroblast growth factor 13 ameliorates amyloid-β-induced neuronal damage
Zhu, H., Li, R., Xiao, L., Zhang, T., & Ren, D. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.357902 · Cited by 14
Li, T., Li, D., Wei, Q., Shi, M., Xiang, J., Gao, R., Chen, C., & Xu, Z. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106114 · Cited by 17
Stamenković, S., Li, Y., Waters, J., & Shih, A. Y. (2023) · Stroke · doi:10.1161/strokeaha.122.037156 · Cited by 14
Zhu, L. J., Wang, M., Liu, Y., Fu, P., Zhang, W., Zhang, H., Roe, A. W., & Wang, X. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112469 · Cited by 14
Capillary dysfunction in healthy elderly APOE ε4 carriers with raised brain Aβ deposition
Madsen, L. S., Kjeldsen, P. L., Ismail, R., Parbo, P., Østergaard, L., Brooks, D. J., & Eskildsen, S. F. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13461 · Cited by 12
“14 The initiation of this purported vicious cycle is, however, unknown and requires investigations of the preclinical stages of the disease.”
BackgroundGastfriend, B. D., Snyder, M. E., Holt, H., Daneman, R., Palecek, S. P., & Shusta, E. V. (2024) · Science Advances · doi:10.1126/sciadv.adi1737 · Cited by 16
“Brain mural cells are also implicated in the pathogenesis of neurological disorders including Alzheimer’s disease ( 19 – 21 ) and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) ( 22 , 23 ).”
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Fang, X., Fan, F., & Roman, R. J. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.087 · Cited by 17
“Loss of pericytes has been associated with capillary rarefaction, cerebral hypoperfusion, and BBB leakage in various animal models and AD patients [13,89,106,186,187,192,193].”
BackgroundInfluentialBonney, S. K., Nielson, C. D., Sosa, M. J., Bonnar, O., & Shih, A. Y. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321021121 · Cited by 14
“Capillaries are the site of amyloid beta buildup during Type 1 cerebral amyloid angiopathy, a form of small vessel disease ( 4 ), and reactive oxygen species induced by amyloid beta toxicity can cause damage to the capillary endothelium and neighboring pericytes ( 5 ).”
BackgroundFernandes, M. G. F., Pernin, F., Antel, J. P., & Kennedy, T. E. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16219 · Cited by 13
Haemodynamic impairment along the Alzheimer’s disease continuum
Diomedi, M., Rocco, A., Bonomi, C. G., Mascolo, A. P., Lucia, V. D., Marrama, F., Sallustio, F., Koch, G., & Martorana, A. (2021) · European Journal of Neurology · doi:10.1111/ene.14834 · Cited by 14
“This activation promotes vasoconstriction impairing vascular reactivity [28].”
BackgroundNot just neurons: The diverse cellular landscape of learning and memory
Alberini, C. M. (2025) · Neuron · doi:10.1016/j.neuron.2025.05.005 · Cited by 13
Zhao, D., Wang, J., Zhu, Y., Zhang, H., Ni, C., Zhao, Z., Dai, J., He, R., Liu, G.-Z., Gan, C., et al. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00510-8 · Cited by 18
“Nortley et al. demonstrated that Aβ amyloid can stimulate microglia to produce reactive oxygen species (ROS), leading to peri-cyte contraction, which is closely related to the cerebral blood flow (CBF) decline in AD patients [71].”
Underly, R. G., & Shih, A. Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.619230 · Cited by 12
“…oxide, stroke INTRODUCTION During stroke, rapid activation of the proteolytic enzyme, matrix-metalloproteinase-9 (MMP9) leads to degradation of the neurovascular unit and compromise of the blood-brain barrier (BBB) (Gasche et al., 1999; Planas et al., 2001; Montaner, 2003; Fukuda et al., 2004).”
BackgroundChum, P. P., Bishara, M. A., Solis, S. R., & Behringer, E. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230300 · Cited by 12
Pluta, R. M., Miziak, B., & Czuczwar, S. J. (2023) · Molecules · doi:10.3390/molecules28155624 · Cited by 12
“Thus, amyloid leads to permanent vasoconstriction by accumulating in the vascular walls and reducing the production of nitric oxide by the endothelium, consequently leading to hypoperfusion or lack of blood flow in these vessels [153].”
BackgroundKing, N. E., Courtney, J., Brown, L. S., Fortune, A. J., Blackburn, N. B., Fletcher, J. L., Cashion, J. M., Talbot, J., Pébay, A., Hewitt, A. W., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03671-x · Cited by 15
Hu, Y., Zhang, F., Ikonomović, M. D., & Yang, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073833 · Cited by 13
“In AD, A β deposition generates excessive ROS and triggers the release of vasoconstrictive peptides such as endothelin-1, altering pericyte tone and causing vasoconstriction [210,211].”
BackgroundVascular Function and Ion Channels in Alzheimer's Disease
Taylor, J. L., Baudel, M. A. S. M., Nieves‐Cintrón, M., & Navedo, M. F. (2024) · Microcirculation · doi:10.1111/micc.12881 · Cited by 13
Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes
El‐Ghazawi, K., Eyo, U. B., & Peirce, S. M. (2024) · Microcirculation · doi:10.1111/micc.12877 · Cited by 14
“In the context of AD, Nortley et al. [75] used rapid-fixed brain tissue and 2-photon live imaging to show that Aß plaque deposition causes constriction of human and rodent cortical capillaries at the pericyte soma, indicating that Aß causes pericyte constriction at the capillary level.”
Cobalt(III) Schiff base complexes stabilize non-fibrillar amyloid-β aggregates with reduced toxicity
Roberts, K. F., Brue, C. R., Preston, A., Baxter, D., Herzog, E., Varelas, E. A., & Meade, T. J. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111265 · Cited by 12
Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
Bryant, A. G., Manhard, M. K., Salat, D. H., Rosen, B. R., Hyman, B. T., Johnson, K. A., Huang, S. Y., Bennett, R. E., & Yen, Y. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211126113904 · Cited by 12
“Both amyloid-β oligomers [70] and the APOE ε4 allele [71] can disrupt microvascular flow via impaired capillary pericyte function, and further study is needed to disentangle their microvascular effects from those of tau pathology.”
Orekhova, K., Centelleghe, C., Guardo, G. D., Graïc, J., Cozzi, B., Trez, D., Verin, R., & Mazzariol, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269090 · Cited by 13
Advancing medicine for Alzheimer’s disease: A plasma neural exosome platform
Goetzl, E. J. (2020) · The FASEB Journal · doi:10.1096/fj.202001655 · Cited by 12
Goirand, F., Georgeot, B., Giraud, O., & Lorthois, S. (2021) · Brain Multiphysics · doi:10.1016/j.brain.2021.100028 · Cited by 17
Endothelial Cells and the Cerebral Circulation
Lansdell, T. A., Chambers, L. C., & Dorrance, A. M. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210015 · Cited by 22
Light‐controlled molecular tweezers capture specific amyloid oligomers
Qian, C., Chen, J., Gao, F., Xian, T., Wang, X., Wang, X., Wang, X., & Wang, X. (2023) · Aggregate · doi:10.1002/agt2.463 · Cited by 11
Efficacy of exercise rehabilitation for managing patients with Alzheimer’s disease
Li, D., Jia, J., Zeng, H., Zhong, X., Chen, H., & Yi, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.391308 · Cited by 15
Enzyme-Responsive Supramolecular Self-Assembly in Small Amphiphiles
Xiao, X., & Huang, J. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c01762 · Cited by 14
Qiao, L., Yi, S., Li, T.-P., Pan, X., Wang, G.-Y., Liu, X., Li, M., Min, J., Le, H.-H., & Tang, Z.-Y. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14292 · Cited by 11
Wellman, S. M., Forrest, A. M., Douglas, M. M., Subbaraman, A., Zhang, G., & Kozai, T. D. Y. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122963 · Cited by 12
White matter hyperintensity spatial patterns: Risk factors and clinical correlates
Beyer, F., Tsuchida, A., Soumaré, A., Rajula, H. S. R., Mishra, A., Crivello, F., Proust‐Lima, C., Loeffler, M., Tzourio, C., Amouyel, P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70053 · Cited by 16
“69,70 Moreover, vascular changes such as stiffness and reduced pulsatile motion of arteries may impair the drainage ofamyloidpeptidesfromperivascularspaceandtherebypromoteamy-loid deposition.”
Self-citationEndothelial ether lipids link the vasculature to blood pressure, behavior, and neurodegeneration
Spears, L. D., Adak, S., Dong, G., Wei, X., Spyropoulos, G., Zhang, Q., Li, Y., Chu, F., Hu, D., Lodhi, I. J., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100079 · Cited by 14
“Cardiovascular-associated genes in addition to APOE are related to dementia (6, 7), consistent with the notion that vascular dysfunction, perhaps exacerbated by amyloid β (8) and tau (9), promotes neurodegeneration.”
BackgroundLiver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2
Vacondio, D., Pinto, H. N., Coenen, L., Mulder, I. A., Fontijn, R. D., Hof, B. V. H., Fung, W. K., Jongejan, A., Kooij, G., Zelcer, N., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06316-8 · Cited by 12
Nakagomi, T., Tanaka, Y., Nakagomi, N., Matsuyama, T., & Yoshimura, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176360 · Cited by 11
“Further, pericyte deficiency causes decreased blood flow [47,72,73] and amyloid β oligomers constrict capillaries in AD through signaling to pericytes, thereby leading to CBF reduction [74].”
BackgroundMikkelsen, A. C. D., Thomsen, K. L., Mookerjee, R. P., & Hadjihambi, A. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01105-2 · Cited by 11
Stamenković, S., Schmid, F., Gürler, G., Abolmaali, F., Weitermann, N. A., Takasaki, K., Bonney, S. K., Sosa, M. J., Bennett, H. C., Kim, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.11.579849 · Cited by 11
Liu, G., & Sun, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374149 · Cited by 11
“30 The progressive loss of synapses leads to neuronal death and brain atrophy, particularly in regions critical for cognitive function, such as the hippocampus and cortex.”
Sharma, N., Kim, D., Sharma, H., Kim, M. I., Lee, H., Kim, M., Ryoo, N., Kang, M. J., Pyun, J., Park, Y. H., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00829-4 · Cited by 10
Protein aggregation and biomolecular condensation in hypoxic environments (Review)
Li, C., Hao, B., Yang, H., Wang, K., Fan, L., & Xiao, W. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5357 · Cited by 10
“…binding of oligomeric β ‑amyloid protein (A β ) to ROS leads to vasoconstriction around brain cells, contributing to decreased cerebral blood flow, which may initiate a cascade reaction involving amyloid A β itself or the fibrous A β , which is important for driving cognitive decline (27,28).”
BackgroundWang, P., Sun, W., Gong, J., Han, X., Xu, C., Chen, Y., Yang, Y., Luan, H., Li, S., Li, R., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082404 · Cited by 10
Edgerton-Fulton, M., Abdul, Y., Jamil, S., & Ergul, A. (2024) · Clinical Science · doi:10.1042/cs20240328 · Cited by 11
Pericyte ablation causes hypoactivity and reactive gliosis in adult mice
Cashion, J. M., Brown, L. S., Morris, G. P., Fortune, A. J., Courtney, J., Makowiecki, K., Premilovac, D., Cullen, C. L., Young, K. M., & Sutherland, B. A. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.014 · Cited by 10
“13A), which is consistent with the hypothesis that HP-1 + cells in the brain are interneurons (Nortley et al., 2019).”
ResultWang, X., Yang, J., Zhang, X., Cai, J., Zhang, J., Cai, C., Zhuo, Y., Fang, S., Xu, X., Wang, H., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156158 · Cited by 12
Reactive Oxygen Species, a Potential Therapeutic Target for Vascular Dementia
White, A. L., Talkington, G. M., Ouvrier, B., Ismael, S., Solch-Ottaiano, R. J., & Bix, G. J. (2024) · Biomolecules · doi:10.3390/biom15010006 · Cited by 11
Al‐Hosni, R., Agostinelli, E., Ilkan, Z., Scofano, L. F., Kaye, R., Dinsdale, R. L., Acheson, K. E., MacDonald, A., Rivers, D. A., Biosa, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17383 · Cited by 11
“ET-1 is a well-characterised, potent pericyte constrictor (Hirunpattarasilp et al., 2022; Korte et al., 2022; Nortley et al., 2019).”
Bai, P., Mondal, P., Liu, Y., Gomm, A., Suen, C., Yang, L., Zhu, B., Sun, H., Ran, C., Shen, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14616 · Cited by 13
Ficiarà, E., Rabbito, R., Roveta, F., Rubino, E., Rainero, I., Guiot, C., & Boschi, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073060 · Cited by 12
“Capillaries in AD brains are constricted by pericytes, which causes a decrease in the CBF [39].”
Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids
Zeng, P.-M., Sun, X.-Y., Li, Y., Wu, W.-D., Huang, J., Cao, D.-D., Qian, P.-J., Ju, X.-C., & Luo, Z. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102601 · Cited by 14
Aβ31–35 Decreases Neprilysin-Mediated Alzheimer’s Amyloid-β Peptide Degradation
Leite, J. P., Lete, M. G., Fowler, S. A., Gimeno, A., Rocha, J. F., Sousa, S. F., Webster, C. I., Jiménez‐Barbero, J., & Gales, L. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00432 · Cited by 11
Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults
Peng, X., Xu, Z., Mo, X., Guo, Q., Yin, J., Xu, M., Peng, Z., Sun, T., Zhou, L., Peng, X., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05102-x · Cited by 10
Metadata
- Authors
- Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., Kyrargyri, V., Pfeiffer, T., Khennouf, L., Madry, C., Gong, H., Richard-Loendt, A., Huang, W., Saito, T., Saido, T. C., Brandner, S., Sethi, H., & Attwell, D.
- Affiliations
- University College London (GB)
- Oregon Health & Science University (US)
- National Hospital for Neurology and Neurosurgery (GB)
- Saarland University (DE)
- RIKEN Center for Brain Science (JP)
- UCL Queen Square Institute of Neurology (GB)
- Corresponding author
- Korte, Nils
- Izquierdo, Pablo
- Hirunpattarasilp, Chanawee
- Mishra, Anusha
- Jaunmuktane, Zane
- Kyrargyri, Vasiliki
- Attwell, David
- ORCID
- Venue
- Science
- Published
- 2019-07-19
- Volume
- 365
- Issue
- 6450
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6658218
- OpenAlex
- W2951514146
- Semantic Scholar
- cc2df1df8221a1fa3d428338a5ead55bc1a47948
- Cited by
- 682
- References
- 53
- Citations by year
- 2026: 64 · 2025: 90 · 2024: 105 · 2023: 108 · 2022: 93 · 2021: 102 · 2020: 102 · 2019: 16
- FWCI
- 34.70
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust (099222, PhD studentship)
- European Research Council (BrainPower & BrainEnergy)
- Deutsche Forschungsgemeinschaft (KI 503/14-1 and SFB894)
- EMBO (Fellowship)
- Lundbeckfonden (Fellowship)
- national institute of health research (Biomedical Research Centre)
- Leonard Wolfson Experimental Neurology Centre (PhD studentship)
- BBSRC (PhD studentship)
- Chulabhorn Royal Academy (PhD studentship)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, pericytes, brain capillaries, cerebral blood flow, vasoconstriction, mouse models of Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Animals, Hypoxia, Biopsy, Capillaries, Cerebral Cortex, Cerebrovascular Circulation, Constriction, Pathologic, Humans, Vascular Resistance, Signal Transduction, Amyloid beta-Peptides, Rats, Sprague-Dawley, Reactive Oxygen Species, Endothelin-1, Pericytes, Receptor, Endothelin A, Mice, Rats, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
